Although scheduling conflicts prevented him from attending in person, Cost Plus Drugs Co-Founder Mark Cuban made a big impact during the Opening Session of this year’s CPESN® USA Mid-Year Leadership Event. In a recorded 18-minute conversation with CPESN Executive Director Troy Trygstad, Cuban tackled pressing questions about the future of pharmacy—aligning perfectly with the meeting’s theme: Moving Forward – Entrepreneurial Pathways for Monetizing Your Expertise. Watch the video here.
Telligen and CPESN Networks were presented with the Health Equity Champion Award at Civitas Networks for Health’s 2024 Annual Conference for their efforts to increase vaccination rates and education at more than 1,000 nursing homes across Iowa, Colorado, Oklahoma, and Illinois. Click here for more information.
CPESN Iowa Luminary Robert Greenwood was the recipient of the 2024 NCPA Calvin J. Anthony Lifetime Achievement Award. Greenwood owns and operates Greenwood Drug Inc., Greenwood Compounding, Osterhaus Pharmacy, and Denver Drug, all located in Iowa. Click here for the announcement.
Elevance Health's Public Policy Institute released a new paper entitled, “Outcomes in Medicaid Members Engaged in Health Plan, PBM & Community Pharmacy Collaboration. Their research highlights the positive effect unique collaborations between Health Plans, their PBMs, and CPESN pharmacies can have on medical service utilization, medical costs, and care quality, particularly for engaged members with chronic conditions.
Click here to check out the paper.
CPESN Iowa pharmacist Matt Osterhaus with Osterhaus Pharmacy in Maquoketa, Iowa penned an editorial entitled, Drug industry middlemen need a good dose of sunlight" that was featured in the Telegraph Herald. Click here to read.
